This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept
Pandemic response
COVID-19 is impacting communities around the world. PATH and our partners are responding.

Small changes, big savings

National malaria control programs (NMCPs) are frequently faced with making decisions that require trade-offs in order to best allocate scarce resources to control and eliminate malaria. With limited budgets, NMCPs need to choose how to fund staff, research, operations, essential drugs and diagnostics, and many other items in a manner that maximizes the potential impact on reducing malaria. A mismatch between product characteristics and NMCP need will result in overspending and opportunity costs because those wasted funds could have been used elsewhere.

This fact sheet explores these potential downstream consequences for NMCPs of upstream decisions made during the product development process on two examples related to diagnostics used in malaria case management.

Publication date: June 2020

Small changes, big savings

132.2 KB PDF

View Resource